Aims and Scope of Annals of Pharmacotherapy
The Annals of Pharmacotherapy is a peer-reviewed medical journal covering all aspects of pharmacotherapy. The journal was established in 1967 as Drug Intelligence. The name changed a few times during its history, to Drug Intelligence and Clinical Pharmacy (DICP) in 1969 and DICP-The Annals of Pharmacotherapy in 1989, before obtaining its current name in 1992. Less
Key Metrics
CiteScore 

5
H-Index 

120
Impact Factor 

< 5
SJR 

Q1Pharmacology (medical)

SNIP 

1.15
Recommended pre-submission checks
Powered by 

Topics Covered on Annals of Pharmacotherapy
Annals of Pharmacotherapy Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS INC |
| Language | Multi-Language |
| Frequency | Monthly |
| General Details | |
| Language | Multi-Language |
| Frequency | Monthly |
| Publication Start Year | 1967 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Annals of Pharmacotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Annals of Pharmacotherapy
Relationship Between Patient's Body Mass Index and Dalbavancin's Effectiveness in the Treatment of Invasive Gram-Positive Infections.
- 1 Jul 2026
- The Annals of pharmacotherapy
Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.
- 30 Jun 2026
- The Annals of pharmacotherapy
Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.
- 29 Jun 2026
- The Annals of pharmacotherapy
Four-Year Evaluation of a Pharmacists-Providers Collaborative Iron Deficiency Clinic in Heart Failure Care.
- 28 Jun 2026
- The Annals of pharmacotherapy
Association Between Renin-Angiotensin System Inhibitors and Antiseizure Medication Burden in Critically Ill Patients With Status Epilepticus.
- 10 Jun 2026
- The Annals of pharmacotherapy
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
- 6 Jun 2026
- The Annals of pharmacotherapy
Relationship Between Patient's Body Mass Index and Dalbavancin's Effectiveness in the Treatment of Invasive Gram-Positive Infections.
- 1 Jul 2026
- The Annals of pharmacotherapy
Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.
- 30 Jun 2026
- The Annals of pharmacotherapy
Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.
- 29 Jun 2026
- The Annals of pharmacotherapy
Four-Year Evaluation of a Pharmacists-Providers Collaborative Iron Deficiency Clinic in Heart Failure Care.
- 28 Jun 2026
- The Annals of pharmacotherapy
Association Between Renin-Angiotensin System Inhibitors and Antiseizure Medication Burden in Critically Ill Patients With Status Epilepticus.
- 10 Jun 2026
- The Annals of pharmacotherapy
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
- 6 Jun 2026
- The Annals of pharmacotherapy